A Study to Investigate the Interaction Between TMP-301 and Cocaine.
Status:
COMPLETED
Trial end date:
2025-05-05
Target enrollment:
Participant gender:
Summary
This will be a randomized, double-blind, placebo-controlled, parallel-group study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of oral TMP-301, given concurrently with cocaine. The study will consist of 4 phases: Screening, Baseline, Treatment, and Follow-up.